Teva Pharmaceutical Industries Ltd - Asset Resilience Ratio

Latest as of December 2018: 0.00%

Teva Pharmaceutical Industries Ltd (TEVA) has an Asset Resilience Ratio of 0.00% as of December 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read TEVA total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

ILA2.00 Million

≈ $5.36K USD Cash + Short-term Investments

Total Assets

ILA60.68 Billion

≈ $162.69 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1994–2018)

This chart shows how Teva Pharmaceutical Industries Ltd's Asset Resilience Ratio has changed over time. See Teva Pharmaceutical Industries Ltd (TEVA) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Teva Pharmaceutical Industries Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Teva Pharmaceutical Industries Ltd (TEVA) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	ILA0.00	0%
Short-term Investments	ILA2.00 Million	0.0%
Total Liquid Assets	ILA2.00 Million	0.00%

Asset Resilience Insights

Limited Liquidity: Teva Pharmaceutical Industries Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Teva Pharmaceutical Industries Ltd Industry Peers by Asset Resilience Ratio

Compare Teva Pharmaceutical Industries Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Henan Newland Pharmaceutical Co. Ltd. A SHE:301277	Drug Manufacturers - Specialty & Generic	31.63%
Hainan Shuangcheng Pharmaceut SHE:002693	Drug Manufacturers - Specialty & Generic	3.29%

Annual Asset Resilience Ratio for Teva Pharmaceutical Industries Ltd (1994–2018)

The table below shows the annual Asset Resilience Ratio data for Teva Pharmaceutical Industries Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2018-12-31	0.00%	ILA2.00 Million ≈ $5.36K	ILA60.68 Billion ≈ $162.69 Million	-0.02pp
2017-12-31	0.02%	ILA14.00 Million ≈ $37.53K	ILA70.61 Billion ≈ $189.32 Million	-0.71pp
2016-12-31	0.73%	ILA679.00 Million ≈ $1.82 Million	ILA92.89 Billion ≈ $249.03 Million	+0.71pp
2015-12-31	0.02%	ILA11.00 Million ≈ $29.49K	ILA54.26 Billion ≈ $145.46 Million	-0.14pp
2014-12-31	0.16%	ILA73.00 Million ≈ $195.71K	ILA46.42 Billion ≈ $124.45 Million	+0.15pp
2013-12-31	0.00%	ILA2.00 Million ≈ $5.36K	ILA47.51 Billion ≈ $127.37 Million	-0.09pp
2010-12-31	0.09%	ILA36.00 Million ≈ $96.51K	ILA39.05 Billion ≈ $104.70 Million	-0.66pp
2009-12-31	0.75%	ILA253.00 Million ≈ $678.28K	ILA33.81 Billion ≈ $90.64 Million	+0.59pp
2008-12-31	0.16%	ILA53.00 Million ≈ $142.09K	ILA32.90 Billion ≈ $88.21 Million	-5.76pp
2007-12-31	5.92%	ILA1.39 Billion ≈ $3.72 Million	ILA23.41 Billion ≈ $62.77 Million	+2.45pp
2006-12-31	3.48%	ILA712.00 Million ≈ $1.91 Million	ILA20.47 Billion ≈ $54.88 Million	-5.53pp
2005-12-31	9.01%	ILA935.50 Million ≈ $2.51 Million	ILA10.39 Billion ≈ $27.85 Million	+6.34pp
2004-12-31	2.67%	ILA256.80 Million ≈ $688.47K	ILA9.63 Billion ≈ $25.82 Million	-2.78pp
2003-12-31	5.44%	ILA322.10 Million ≈ $863.54K	ILA5.92 Billion ≈ $15.86 Million	+0.35pp
2002-12-31	5.09%	ILA235.70 Million ≈ $631.90K	ILA4.63 Billion ≈ $12.40 Million	+4.48pp
2001-12-31	0.61%	ILA21.23 Million ≈ $56.91K	ILA3.46 Billion ≈ $9.28 Million	+0.48pp
2000-12-31	0.14%	ILA3.90 Million ≈ $10.46K	ILA2.86 Billion ≈ $7.66 Million	-0.87pp
1999-12-31	1.01%	ILA17.23 Million ≈ $46.18K	ILA1.71 Billion ≈ $4.60 Million	+0.86pp
1998-12-31	0.15%	ILA2.10 Million ≈ $5.63K	ILA1.44 Billion ≈ $3.85 Million	-0.50pp
1997-12-31	0.65%	ILA7.70 Million ≈ $20.64K	ILA1.19 Billion ≈ $3.19 Million	+0.00pp
1996-12-31	0.64%	ILA8.00 Million ≈ $21.45K	ILA1.24 Billion ≈ $3.33 Million	-0.54pp
1995-12-31	1.18%	ILA10.30 Million ≈ $27.61K	ILA871.30 Million ≈ $2.34 Million	-0.05pp
1994-12-31	1.23%	ILA8.30 Million ≈ $22.25K	ILA676.00 Million ≈ $1.81 Million	--

pp = percentage points

About Teva Pharmaceutical Industries Ltd

TA:TEVA Israel Drug Manufacturers - Specialty & Generic

Market Cap

$32.34 Billion

ILA12.06 Trillion ILA

Market Cap Rank

#8746 Global

#88 in Israel

Share Price

ILA10360.00

Change (1 day)

-1.33%

52-Week Range

ILA5374.00 - ILA11350.00

All Time High

ILA25447.60